Venture

LOGO 2-01

Technologies

Therapeutic

Indication

Basic Research

Clinical Research

Oncology

Additional Information

Women Founded

Our product is a nanoparticle that localizes and carries drug therapy to the kidney, thus delivering the first targeted treatment for acute kidney injury.

Team:
Paige Yellen, PhD – Founder, CEO